Published in J Clin Invest on October 01, 1993
Natriuretic peptides and therapeutic applications. Heart Fail Rev (2007) 1.44
Novel bifunctional natriuretic peptides as potential therapeutics. J Biol Chem (2008) 1.16
Designer natriuretic peptides. J Investig Med (2009) 0.77
AC-NP: a novel chimeric peptide with natriuretic and vasorelaxing actions. PLoS One (2011) 0.77
Neuroendocrine changes in chronic cardiac failure. Basic Res Cardiol (1996) 0.76
Designer natriuretic peptides. J Clin Invest (1993) 0.75
Innovative Therapeutics: Designer Natriuretic Peptides. JACC Basic Transl Sci (2016) 0.75
Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem (1972) 8.24
A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci (1981) 6.39
Atrial natriuretic peptide elevation in congestive heart failure in the human. Science (1986) 3.37
Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science (1991) 2.25
The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell (1989) 2.07
Purification and sequence analysis of bioactive atrial peptides (atriopeptins). Science (1984) 1.85
Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". J Clin Invest (1992) 1.78
Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol (1984) 1.71
C-type natriuretic peptide (CNP) in rats and humans. Endocrinology (1991) 1.54
Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol (1992) 1.27
Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol (1993) 1.26
Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol (1992) 1.23
C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol (1993) 1.19
Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol Cell Biol (1991) 1.08
Renal receptors for atrial and C-type natriuretic peptides in the rat. Am J Physiol (1992) 0.93
C-type natriuretic peptide immunoreactivity in human breast vascular endothelial cells. Peptides (1993) 0.87
Differential control of blood pressure and heart rate by carotid and aortic baroreceptors in unanaesthetized cats. J Hypertens (1987) 0.80
Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development (2001) 5.46
The genes for fifteen ribosomal proteins of Saccharomyces cerevisiae. J Biol Chem (1981) 4.02
The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med (1992) 3.53
Atrial natriuretic peptide elevation in congestive heart failure in the human. Science (1986) 3.37
Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet (1993) 3.34
Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons. Dev Biol (2000) 2.93
Modulation of vascular smooth muscle contraction by the endothelium. Annu Rev Physiol (1986) 2.76
Messenger RNA for ribosomal proteins in yeast. J Mol Biol (1983) 2.41
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension (1996) 2.37
Sporulation of Clostridium perfringens in a modified medium and selected foods. Appl Microbiol (1967) 2.36
KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric (2005) 2.32
The nifA gene of Rhizobium meliloti is oxygen regulated. J Bacteriol (1987) 2.32
Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med (1991) 2.22
Mild temperature shock alters the transcription of a discrete class of Saccharomyces cerevisiae genes. Mol Cell Biol (1983) 2.19
Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation (1998) 2.08
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res (1993) 1.98
Atrial natriuretic peptide and blood pressure in a population-based sample. Mayo Clin Proc (1995) 1.98
Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. J Immunol (1997) 1.87
Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke (2000) 1.83
A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet (2001) 1.80
Natriuretic peptide system in human heart failure. Circulation (1993) 1.79
The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol (2009) 1.78
Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis (1987) 1.77
Survival of Clostridium perfringens During Baking and Holding of Turkey Stuffing. Appl Microbiol (1966) 1.73
C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J Immunol (2001) 1.71
Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol (1984) 1.71
Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc (1992) 1.70
Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study. Heart (2009) 1.69
Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatr Infect Dis (1983) 1.62
Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn. Eur J Immunol (1999) 1.61
The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med (1998) 1.60
Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res (1988) 1.58
Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther (1988) 1.57
Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. Circulation (1990) 1.57
Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest (1989) 1.57
Effect of a lipidic extract from lepidium meyenii on sexual behavior in mice and rats. Urology (2000) 1.56
Endothelin in human congestive heart failure. Circulation (1994) 1.56
Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation (1995) 1.55
Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol (1990) 1.55
Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain. Mayo Clin Proc (1998) 1.53
Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure. J Clin Invest (1988) 1.53
Schatzki's ring: long-term results following dilation. Gastrointest Endosc (1990) 1.51
The membrane topology of the fusion peptide region of influenza hemagglutinin determined by spin-labeling EPR. J Mol Biol (1997) 1.51
In vitro evaluation of endothelial and smooth muscle function of primary varicose veins. J Vasc Surg (1992) 1.51
Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol (1992) 1.50
Specific stimulation of simian virus 40 late transcription in vitro by a cellular factor binding the simian virus 40 21-base-pair repeat promoter element. Proc Natl Acad Sci U S A (1987) 1.50
An extended medial to lateral approach to mobilize the splenic flexure during laparoscopic low anterior resection. Colorectal Dis (2013) 1.47
Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat Immunol (2001) 1.47
Mechanical consequence of trabecular bone loss and its treatment: a three-dimensional model simulation. Bone (2002) 1.47
Innate immunity as orchestrator of stem cell mobilization. Leukemia (2010) 1.46
Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice. Am J Physiol Heart Circ Physiol (2001) 1.44
The complete amino acid sequence of bovine heart cytochrome C1. Biochem Biophys Res Commun (1980) 1.43
Expression of atrial natriuretic factor in the human ventricle is independent of chamber dilation. J Am Coll Cardiol (1990) 1.41
Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol (1992) 1.41
Pregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretin. J Obstet Gynaecol (2009) 1.39
Cryptic reproductive isolation in the Drosophila simulans species complex. Evolution (2001) 1.36
Endothelial alpha 2-adrenoceptors in canine pulmonary and systemic blood vessels. Eur J Pharmacol (1985) 1.33
Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J Dent Res (2011) 1.32
Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol (1998) 1.32
A tetrodotoxin-producing Vibrio strain, LM-1, from the puffer fish Fugu vermicularis radiatus. Appl Environ Microbiol (2000) 1.31
Renal interstitial pressure and sodium excretion during renal vein constriction. Am J Physiol (1980) 1.31
A relation between inhibition of protein synthesis and conformation of 5'-phosphorylated 7-methylguanosine derivatives. J Mol Biol (1977) 1.31
Overlapping transcription of the nifA regulatory gene in Rhizobium meliloti. Gene (1986) 1.30
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc (2001) 1.29
Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol (2000) 1.28
Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol (1992) 1.27
Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol (1993) 1.26
NIGMS human/rodent somatic cell hybrid mapping panels 1 and 2. Genomics (1993) 1.25
Adenylate kinase-catalyzed phosphotransfer in the myocardium : increased contribution in heart failure. Circ Res (1999) 1.24
Genetic structuring and transfer of marine dinoflagellate Cochlodinium polykrikoides in Japanese and Korean coastal waters revealed by microsatellites. Mol Ecol (2009) 1.24
Failing energetics in failing hearts. Curr Cardiol Rep (2000) 1.24
Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol (1992) 1.23
Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? Circulation (2001) 1.23
Goat blood agar. Inexpensive media for culturing common bacterial pathogens. Trop Doct (1986) 1.23
Sonic hedgehog participates in craniofacial morphogenesis and is down-regulated by teratogenic doses of retinoic acid. Dev Biol (1997) 1.22
Adrenomedullin: potential in physiology and pathophysiology. Life Sci (2000) 1.22
Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J Immunol (1999) 1.22
Characterization of a bifunctional enzyme fusion of trehalose-6-phosphate synthetase and trehalose-6-phosphate phosphatase of Escherichia coli. Appl Environ Microbiol (2000) 1.20
The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc Assoc Am Physicians (1999) 1.20
C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol (1993) 1.19
Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation (1995) 1.18
RNA sequence and secondary structural determinants in a minimal viral promoter that directs replicase recognition and initiation of genomic plus-strand RNA synthesis. J Mol Biol (1999) 1.18
Heterogeneity of endothelium-dependent responses in mammalian blood vessels. J Cardiovasc Pharmacol (1985) 1.16
Spatial configuration of mRNA 5'-terminus. Nature (1977) 1.15
Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure. Kidney Int (1996) 1.15
Paired-like homeodomain proteins, Phox2a and Phox2b, are responsible for noradrenergic cell-specific transcription of the dopamine beta-hydroxylase gene. J Neurochem (1998) 1.13
Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens (2000) 1.12
CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J Immunol (1999) 1.11
Mechanisms of conspecific sperm precedence in Drosophila. Evolution (2000) 1.10
Modulation of endothelium-dependent responses by chronic alterations of blood flow. Am J Physiol (1986) 1.09
A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study. Am Heart J (1999) 1.09
Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. Am J Chin Med (2000) 1.09
Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes Res Clin Pract (2001) 1.08
Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities. Exp Hematol (1999) 1.08
Development of the stress response inventory and its application in clinical practice. Psychosom Med (2001) 1.08
Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors. Ann N Y Acad Sci (1999) 1.08